Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
TAS-301 (0
19(1):291-300
It has the same configuration at all ten stereocentres as pancuronium
is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity
LDK 378 dihydrochloride
BMS-690514 Catalog No.:M10884-10 TAS-301 (0BMS 690514 is a potent inhibitor of human epidermal growth factor receptor (HER) 1 (EGFR), 2, and 4, and vascular endothelial growth factor receptors (VEGFR) 1 3. BMS 690514 is currently under investigation as an oral agent for the treatment of solid tumors. In vitro and in vivo studies were conducted to characterize the pharmacokinetics and metabolism. Through integration of in vitro and in vivo pharmacokinetic data and antitumor efficacy in nude
US$ 18.00
US$ 11.00
US$ 10.00
US$ 10.00
US$ 288.75
US$ 24.00